[Elsevier] [Supplementary]Efficacy and safety of once-weekly semaglutide 2﹞4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial |
|
This post will be closed automatically in 2026-08-02 07:27
Reward20points
|
post
reply
points
20
10
The Teleologic Basis of Kidney Potassium Handling: A Conceptual Review
20
[Supplementary]Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
20
Evolution of a core ribosomal innovation in octopus
10
Solar Thermal Systems: Components and Applications〞Introduction
10
Immunopathology of immune thrombocytopenia
